People living with chronic pain are two to three times more likely to die by suicide than those without pain.
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
The claim that people living with chronic pain are two to three times more likely to die by suicide than those without pain is broadly supported by the peer-reviewed literature: multiple reviews and clinical analyses conclude that suicide risk among people with chronic pain is at least doubled compared with the general population [1] [2] [3]. That increased risk is robust across many studies, but important caveats — especially confounding by depression, substance use, and methodological heterogeneity — mean the “two to three times” figure should be treated as a summary estimate rather than a precise universal multiplier [4] [5] [6].
1. Evidence that chronic pain elevates suicide risk
Large reviews and meta-analyses consistently report higher suicidal ideation, attempts, and deaths in chronic pain populations, with authors explicitly stating that individuals with chronic pain are at least twice as likely to report suicidal behaviors or die by suicide compared to those without pain [1] [3] [2]. Epidemiologic analyses of violent-death reporting systems found that chronic pain was documented in nearly 9% of suicide decedents in multi-state U.S. data, a nontrivial share that rose over time and aligns with other studies linking chronic pain to suicide outcomes [7] [8]. Systematic reviews of observational studies also show high pooled prevalences of suicidal ideation in mixed chronic-pain samples, with short-term ideation rates comparable to psychiatric high-risk groups in some analyses [5] [9].
2. Why “two to three times” is a defensible but imperfect shorthand
Authors of major reviews use language such as “at least twice” to summarize the literature, which validates the lower bound of the two-to-three-times claim while signaling uncertainty about exact magnitude [1] [2]. Meta-analytic prevalence estimates for suicidal ideation and cohort studies of suicide mortality vary widely, producing heterogeneity that precludes a single precise multiplier for every pain population or setting [5] [9]. Longitudinal and registry studies often find elevated risk, but effect sizes change depending on whether researchers adjust for psychiatric comorbidity, socioeconomic status, or pain comorbidity — hence a pooled "2–3x" is a reasonable summary but not a one-size-fits-all truth [6] [4].
3. Mechanisms and mediators: what really drives the association
Evidence points to both direct and indirect pathways: chronic pain itself appears to contribute to suicidality, but much of the increased suicide mortality is also explained by co-occurring depression, substance use disorders, hopelessness, and feelings such as mental defeat and perceived burdensomeness [4] [10] [11]. Prospective work shows psychosocial variables like mental defeat and perceived stress predict subsequent suicide risk even after controlling for some covariates, suggesting pain-related psychological processes add unique risk beyond classic psychiatric diagnoses [10].
4. Contrasting evidence and methodological limits
Not all analyses point to a simple causal effect; co-twin control studies and multivariable models that adjust for pain comorbidities and familial confounding show attenuation of many associations, implying that shared familial factors, psychopathology, or unmeasured confounders may account for part of the link between pain and suicidal behavior [6]. Reviews also highlight large heterogeneity across studies, variable definitions of chronic pain and suicidality, and difficulty measuring pain severity versus psychosocial impact, which weakens claims of a uniform 2–3x increase [5] [6].
5. Practical implications and divergent emphases in reporting
Clinical and public-health sources converge on the need to screen for suicidality among patients with chronic pain and to address modifiable psychosocial risks [1] [2]. Some reporting emphasizes pain itself as the primary driver, while others underscore mediators like depression and opioid access — these different emphases reflect implicit agendas: pain-focused narratives press for better analgesic care, while mental-health–focused narratives press for psychiatric and substance-use interventions [4] [7].
6. Bottom line
The statement that people with chronic pain are two to three times more likely to die by suicide than those without is supported as a cautious, literature-backed summary: many authoritative reviews report at least a doubling of suicide risk, but heterogeneity, confounding, and differing methodologies mean the multiplier varies by population and study [1] [2] [6]. Future research needs clearer causal models and intervention trials targeting both pain and its psychosocial sequelae to move beyond summary multipliers toward actionable prevention strategies [10] [5].